Metabolomics Workbench : NIH Data Repository

(Analysis AN000557)

Values for each metabolite have been scaled by dividing by the mean across all factors

Metabolite	F1	F2
1_CE (22:1) iSTD	1.0523	0.9477
1_Ceramide C17 iSTD	1.0921	0.9079
1_Cholesterol d7 iSTD	1.1445	0.8555
1_CUDA (pos) iSTD	1.0404	0.9596
1_DG (12:0/12:0/0:0) iSTD	1.3734	0.6266
1_DG (18:1/2:0/0:0) iSTD	1.3338	0.6662
1_LPC (17:0) iSTD	1.1741	0.8259
1_LPE (17:1) iSTD	1.1187	0.8813
1_MG (17:0/0:0/0:0) iSTD	1.1174	0.8826
1_PC (25:0) iSTD	1.1683	0.8317
1_PE (17:0/17:0) iSTD	1.1345	0.8655
1_SM (d35:1) iSTD	1.1721	0.8279
1_Sphingosine (d17:1) iSTD	1.1502	0.8498
1_TG (17:0/17:1/17:0)-d5 iSTD	1.2622	0.7378
Ceramide (d40:1)	1.2898	0.7102
Ceramide (d42:1)	1.2795	0.7205
Ceramide (d42:2)	1.1557	0.8443
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)	1.0755	0.9245
GlcCer (d40:1)	1.1964	0.8036
GlcCer (d42:1)	1.1795	0.8205
GlcCer (d42:2)	1.0141	0.9859
Lactosylceramide (d18:1/24:1(15Z))	1.1379	0.8621
PC (28:0)	1.2117	0.7883
PC (30:0)	1.1374	0.8626
PC (30:1)	1.1670	0.8330
PC (32:1)	1.1415	0.8585
PC (32:3)	1.1534	0.8466
PC (36:1)	1.1467	0.8533
PC (38:2)	0.9915	1.0085
PC (38:4) B	1.0989	0.9011
PC (40:1)	1.1152	0.8848
PC (40:2)	1.0267	0.9733
PC (42:1)	1.1187	0.8813
PC (42:2)	1.0428	0.9572
PC (p-34:3) or PC (o-34:4)	1.2856	0.7144
PC (p-36:0) or PC (o-36:1)	1.1413	0.8587
PC (p-36:1) or PC (o-36:2)	1.0083	0.9917
PC (p-36:3) or PC (o-36:4)	1.1289	0.8711
PE (32:1)	1.1642	0.8358
PE (34:1)	1.1431	0.8569
PE (34:2)	1.1310	0.8690
PE (36:1)	1.1868	0.8132
PE (36:2)	0.8669	1.1331
PE (p-32:1) oe PE (o-32:2)	1.2122	0.7878
PE (p-34:1) or PE (o-34:2)	1.1570	0.8430
PE (p-36:1) or PE (o-36:2)	1.1793	0.8207
PE (p-36:2) or PE (o-36:3)	1.0578	0.9422
SM (d34:0)	1.1437	0.8563
SM (d40:0)	1.2969	0.7031
SM (d42:0)	1.3102	0.6898

F1	Treatment:Control
F2	Treatment:Lipid Supplement